ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $651,585 | -14.7% | 36,300 | -3.5% | 0.00% | 0.0% |
| Q2 2023 | $763,656 | -63.7% | 37,600 | -67.4% | 0.00% | -60.0% |
| Q1 2023 | $2,104,896 | -40.9% | 115,400 | -33.0% | 0.01% | -50.0% |
| Q4 2022 | $3,563,164 | -22.1% | 172,300 | -1.4% | 0.01% | -23.1% |
| Q3 2022 | $4,573,000 | +34.8% | 174,800 | +30.5% | 0.01% | +30.0% |
| Q2 2022 | $3,393,000 | -30.5% | 133,900 | -13.5% | 0.01% | -23.1% |
| Q1 2022 | $4,885,000 | -56.3% | 154,800 | -43.9% | 0.01% | -53.6% |
| Q4 2021 | $11,170,000 | +10.0% | 276,000 | -5.3% | 0.03% | +7.7% |
| Q3 2021 | $10,158,000 | -1.8% | 291,300 | -22.6% | 0.03% | -3.7% |
| Q2 2021 | $10,339,000 | -21.1% | 376,500 | -19.3% | 0.03% | -25.0% |
| Q1 2021 | $13,097,000 | +2.7% | 466,400 | -5.0% | 0.04% | +5.9% |
| Q4 2020 | $12,749,000 | +36.1% | 491,100 | -10.2% | 0.03% | +25.9% |
| Q3 2020 | $9,369,000 | +50.2% | 546,600 | +116.8% | 0.03% | +50.0% |
| Q2 2020 | $6,237,000 | +505.5% | 252,100 | +239.8% | 0.02% | +350.0% |
| Q1 2020 | $1,030,000 | +39.2% | 74,200 | +1.2% | 0.00% | +100.0% |
| Q4 2019 | $740,000 | – | 73,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |